Okada Akira, Honda Akira, Watanabe Hideaki, Sasabuchi Yusuke, Aso Shotaro, Kurakawa Kayo Ikeda, Nangaku Masaomi, Yamauchi Toshimasa, Yasunaga Hideo, Chikuda Hirotaka, Kadowaki Takashi, Yamaguchi Satoko
Department of Prevention of Diabetes and Lifestyle-Related Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Orthopaedic Surgery, Gunma University Graduate School of Medicine, Gunma, Japan.
Clin Kidney J. 2023 Dec 12;17(1):sfad302. doi: 10.1093/ckj/sfad302. eCollection 2024 Jan.
Proteinuria is associated with an increased risk of kidney function deterioration, cardiovascular disease, or cancer. Previous reports suggesting an association between kidney dysfunction and bone fracture may be confounded by concomitant proteinuria and were inconsistent regarding the association between proteinuria and bone fracture. Therefore, we aimed to evaluate the association using a large administrative claims database in Japan.
Using the DeSC database, we retrospectively identified individuals with laboratory data including urine dipstick test between August 2014 and February 2021. We evaluated the association between proteinuria and vertebral or hip fracture using multivariable Cox regression analyses adjusted for various background factors including kidney function. We also performed subgroup analyses stratified by sex and kidney function and sensitivity analyses with Fine & Gray models considering death as a competing risk.
We identified 603 766 individuals and observed 21 195 fractures. With reference to the negative proteinuria group, the hazard ratio for hip or vertebral fracture was 1.10 [95% confidence interval (CI), 1.05-1.14] and 1.16 (95%CI, 1.11-1.22) in the trace and positive proteinuria group, respectively, in the Cox regression analysis. The subgroup analyses showed similar trends. The Fine & Gray model showed a subdistribution hazard ratio of 1.09 (95%CI, 1.05-1.14) in the trace proteinuria group and 1.15 (95% CI, 1.10-1.20) in the positive proteinuria group.
Proteinuria was associated with an increased risk of developing hip or vertebral fractures after adjustment for kidney function. Our results highlight the clinical importance of checking proteinuria for predicting bone fractures.
蛋白尿与肾功能恶化、心血管疾病或癌症风险增加相关。先前有关肾功能不全与骨折之间关联的报告可能受到伴随蛋白尿的影响而产生混淆,并且蛋白尿与骨折之间的关联也不一致。因此,我们旨在利用日本一个大型行政索赔数据库评估这种关联。
使用DeSC数据库,我们回顾性地识别出在2014年8月至2021年2月期间有包括尿试纸条检测在内的实验室数据的个体。我们使用多变量Cox回归分析评估蛋白尿与椎体或髋部骨折之间的关联,并对包括肾功能在内的各种背景因素进行了调整。我们还按性别和肾功能进行了亚组分析,并使用考虑死亡为竞争风险的Fine & Gray模型进行了敏感性分析。
我们识别出603766名个体,并观察到21195例骨折。在Cox回归分析中,与蛋白尿阴性组相比,微量蛋白尿组和蛋白尿阳性组髋部或椎体骨折的风险比分别为1.10 [95%置信区间(CI),1.05 - 1.14] 和1.16(95%CI,1.11 - 1.22)。亚组分析显示了类似的趋势。Fine & Gray模型显示微量蛋白尿组的亚分布风险比为1.09(95%CI,1.05 - 1.14),蛋白尿阳性组为1.15(95%CI,1.10 - 1.20)。
在调整肾功能后,蛋白尿与髋部或椎体骨折发生风险增加相关。我们的结果突出了检测蛋白尿对预测骨折的临床重要性。